<?xml version="1.0" encoding="utf-8"?>
<journal>
	<language>en</language>
	<journal_id_issn></journal_id_issn>
	<journal_id_issn_online>2008-2290</journal_id_issn_online>
	<journal_id_pii></journal_id_pii>
	<journal_id_doi></journal_id_doi>
	<journal_id_isnet></journal_id_isnet>
	<journal_id_iranmedex></journal_id_iranmedex>
	<journal_id_magiran></journal_id_magiran>
	<journal_id_sid></journal_id_sid>
	<pubdate>
		<type>gregorian</type>
		<year>2011</year>
		<month>7</month>
		<day>30</day>
	</pubdate>
	<pubdate>
		<type>jalali</type>
		<year></year>
		<month></month>
		<day></day>
	</pubdate>
	<volume>3</volume>
	<number>2</number>
	<publish_type>online</publish_type>
	<publish_edition>11</publish_edition>
	<article_type>fulltext</article_type>
	<articleset>
		
		<article>
			<language></language>
			<article_id_issn></article_id_issn>
			<article_id_issn_online></article_id_issn_online>
			<article_id_pubmed></article_id_pubmed>
			<article_id_pii></article_id_pii>
			<article_id_doi></article_id_doi>
			<article_id_iranmedex></article_id_iranmedex>
			<article_id_magiran></article_id_magiran>
			<article_id_sid></article_id_sid>
			<title_fa></title_fa>
			<title>Does Clopidogrel Increase Blood Loss Following Coronary Artery Bypass Surgery?</title>
			<subject_fa></subject_fa>
			<subject></subject>
			<content_type_fa></content_type_fa>
			<content_type>Original Article</content_type>
			<abstract_fa></abstract_fa>
			<abstract>&lt;p&gt;Clopidogrel treatment is associated with a reduction in thrombotic complications in&lt;br /&gt;coronary stent placement, improved outcome after acute coronary syndromes and decreased&lt;br /&gt;mortality in patients with coronary artery disease. The purpose of this study&lt;br /&gt;was to analyze the effect of preoperative clopidogrel exposure on bleeding complications,&lt;br /&gt;blood transfusion requirement and reoperations and ICU and ward stay and mediastinitis&lt;br /&gt;in patients undergoing coronary artery bypass grafting (CABG).&lt;/p&gt;</abstract>
			<keyword_fa></keyword_fa>
			<keyword>CABG; clopidogrel; postoperative blood loss</keyword>
			<start_page>25</start_page>
			<end_page>29</end_page>
			<web_url>http://www.iscs.org.ir/journals/vol.3/no.2/334/</web_url>
			<author_list>
				
			</author_list>
		</article>
		
		<article>
			<language></language>
			<article_id_issn></article_id_issn>
			<article_id_issn_online></article_id_issn_online>
			<article_id_pubmed></article_id_pubmed>
			<article_id_pii></article_id_pii>
			<article_id_doi></article_id_doi>
			<article_id_iranmedex></article_id_iranmedex>
			<article_id_magiran></article_id_magiran>
			<article_id_sid></article_id_sid>
			<title_fa></title_fa>
			<title>Cardiovascular Malformations in Congenital Rubella Syndrome: A Case Report</title>
			<subject_fa></subject_fa>
			<subject></subject>
			<content_type_fa></content_type_fa>
			<content_type>Review</content_type>
			<abstract_fa></abstract_fa>
			<abstract>&lt;p&gt;Congenital rubella syndrome (CRS) has a wide variety of severe systemic complications.&lt;br /&gt;Cardiovascular defects have always been a part of the rubella syndrome. Patent&lt;br /&gt;ductus arteriosus (PDA) remains the most frequent cardiac anomaly. It may occur&lt;br /&gt;alone or accompany other heart defects. Pulmonary stenosis and septal defects have&lt;br /&gt;been noted with greater frequency since the earlier reports. The classic triad is hearing impairment,&lt;br /&gt;heart defect, and cataract.&lt;br /&gt;Here we report an infant girl with classic presentations of CRS. We discuss about her malformations&lt;br /&gt;and compared them with other combination of manifestations in the literature.&lt;/p&gt;</abstract>
			<keyword_fa></keyword_fa>
			<keyword>Congenital, Rubella infection, Cardiac anomaly</keyword>
			<start_page>0</start_page>
			<end_page>0</end_page>
			<web_url>http://www.iscs.org.ir/journals/vol.3/no.2/333/</web_url>
			<author_list>
				
			</author_list>
		</article>
		
		<article>
			<language></language>
			<article_id_issn></article_id_issn>
			<article_id_issn_online></article_id_issn_online>
			<article_id_pubmed></article_id_pubmed>
			<article_id_pii></article_id_pii>
			<article_id_doi></article_id_doi>
			<article_id_iranmedex></article_id_iranmedex>
			<article_id_magiran></article_id_magiran>
			<article_id_sid></article_id_sid>
			<title_fa></title_fa>
			<title>Hydatid Cyst of the Left Ventricle, Interven-tricular Septum , Liver and Lung</title>
			<subject_fa></subject_fa>
			<subject></subject>
			<content_type_fa></content_type_fa>
			<content_type>Review</content_type>
			<abstract_fa></abstract_fa>
			<abstract>&lt;p&gt;Cardiac Echinococcosis is a rare and the most serious of all Hydatid manifestation. We&lt;br /&gt;report here the case of 12 year old boy who had Hydatid Cyst in the liver, lung , left&lt;br /&gt;ventricle &amp;amp; inter ventricular septum .&lt;br /&gt;The patient underwent cardiac surgery after 2 months medical therapy with Albendazole.&lt;/p&gt;</abstract>
			<keyword_fa></keyword_fa>
			<keyword>-</keyword>
			<start_page>0</start_page>
			<end_page>0</end_page>
			<web_url>http://www.iscs.org.ir/journals/vol.3/no.2/332/</web_url>
			<author_list>
				
			</author_list>
		</article>
		
		<article>
			<language></language>
			<article_id_issn></article_id_issn>
			<article_id_issn_online></article_id_issn_online>
			<article_id_pubmed></article_id_pubmed>
			<article_id_pii></article_id_pii>
			<article_id_doi></article_id_doi>
			<article_id_iranmedex></article_id_iranmedex>
			<article_id_magiran></article_id_magiran>
			<article_id_sid></article_id_sid>
			<title_fa></title_fa>
			<title>The Ross Operation in Children and Young Adults: A Fifteen-Year,Single-Institution Experience</title>
			<subject_fa></subject_fa>
			<subject></subject>
			<content_type_fa></content_type_fa>
			<content_type>Review</content_type>
			<abstract_fa></abstract_fa>
			<abstract>&lt;p&gt;The optimal operation for aortic valve disease&lt;br /&gt;in children and young adults remains controversial.&lt;br /&gt;The Ross operation offers avoidance of anticoagulation and&lt;br /&gt;the potential for growth but is technically demanding and&lt;br /&gt;creates double-valve disease. The goal of this study is to&lt;br /&gt;report our experience with the Ross operation and the need&lt;br /&gt;for reintervention at intermediate follow-&lt;/p&gt;</abstract>
			<keyword_fa></keyword_fa>
			<keyword>-</keyword>
			<start_page>0</start_page>
			<end_page>0</end_page>
			<web_url>http://www.iscs.org.ir/journals/vol.3/no.2/331/</web_url>
			<author_list>
				
			</author_list>
		</article>
		
		<article>
			<language></language>
			<article_id_issn></article_id_issn>
			<article_id_issn_online></article_id_issn_online>
			<article_id_pubmed></article_id_pubmed>
			<article_id_pii></article_id_pii>
			<article_id_doi></article_id_doi>
			<article_id_iranmedex></article_id_iranmedex>
			<article_id_magiran></article_id_magiran>
			<article_id_sid></article_id_sid>
			<title_fa></title_fa>
			<title>Comparison of surgical and interventional therapy of native and recurrent aortic coarc-tation regarding different age groups during childhood</title>
			<subject_fa></subject_fa>
			<subject></subject>
			<content_type_fa></content_type_fa>
			<content_type>Review</content_type>
			<abstract_fa></abstract_fa>
			<abstract>&lt;p&gt;The aim of the study was to analyze immediate&lt;br /&gt;results, rate of complications and re-interventions during&lt;br /&gt;medium-term outcome in pediatric patients with native or&lt;br /&gt;recurrent aortic coarctation. We focused on an age-related&lt;br /&gt;therapeutic approach comparing surgical and trans-catheter&lt;br /&gt;treatment.&lt;/p&gt;</abstract>
			<keyword_fa></keyword_fa>
			<keyword>Aortic coarctation, Pediatric cardiac surgery,Stent, Trans-catheter treatment, Balloon dilatation.</keyword>
			<start_page>0</start_page>
			<end_page>0</end_page>
			<web_url>http://www.iscs.org.ir/journals/vol.3/no.2/330/</web_url>
			<author_list>
				
			</author_list>
		</article>
		
		<article>
			<language></language>
			<article_id_issn></article_id_issn>
			<article_id_issn_online></article_id_issn_online>
			<article_id_pubmed></article_id_pubmed>
			<article_id_pii></article_id_pii>
			<article_id_doi></article_id_doi>
			<article_id_iranmedex></article_id_iranmedex>
			<article_id_magiran></article_id_magiran>
			<article_id_sid></article_id_sid>
			<title_fa></title_fa>
			<title>Relevance of colloid oncotic pressure regulation during neonatal and infant cardiopulmonary bypass: a prospective randomized study</title>
			<subject_fa></subject_fa>
			<subject></subject>
			<content_type_fa></content_type_fa>
			<content_type>Review</content_type>
			<abstract_fa></abstract_fa>
			<abstract>&lt;p&gt;In neonatal and infant cardiac surgery with cardiopulmonary&lt;br /&gt;bypass (CPB), hemodilution with reduction&lt;br /&gt;of plasma albumin concentration and low colloid oncotic&lt;br /&gt;pressure (COP) are the main factors associated with tissue&lt;br /&gt;edema and postoperative weight gain. The aim of our study&lt;br /&gt;was to evaluate the influence of two different COP regulatory&lt;br /&gt;strategies on post-bypass body weight gain, fluid balance,&lt;br /&gt;and clinical outcomes.&lt;/p&gt;</abstract>
			<keyword_fa></keyword_fa>
			<keyword>Infant and neonatal cardiopulmonary bypass,Colloid oncotic pressure, Albumin concentration, Fluid balance</keyword>
			<start_page>0</start_page>
			<end_page>0</end_page>
			<web_url>http://www.iscs.org.ir/journals/vol.3/no.2/329/</web_url>
			<author_list>
				
			</author_list>
		</article>
		
		<article>
			<language></language>
			<article_id_issn></article_id_issn>
			<article_id_issn_online></article_id_issn_online>
			<article_id_pubmed></article_id_pubmed>
			<article_id_pii></article_id_pii>
			<article_id_doi></article_id_doi>
			<article_id_iranmedex></article_id_iranmedex>
			<article_id_magiran></article_id_magiran>
			<article_id_sid></article_id_sid>
			<title_fa></title_fa>
			<title>Long-term results of one-and-a-half ventricle repair in complex cardiac anomalies</title>
			<subject_fa></subject_fa>
			<subject></subject>
			<content_type_fa></content_type_fa>
			<content_type>Review</content_type>
			<abstract_fa></abstract_fa>
			<abstract>&lt;p&gt;One-and-a-half ventricle repair is a surgical&lt;br /&gt;option for complex cardiac anomalies characterized by&lt;br /&gt;right-ventricle hypoplasia or dysfunction. The long-term&lt;br /&gt;result analyses or large clinical reviews are rare. The aim&lt;br /&gt;of this study is to evaluate the long-term functional results&lt;br /&gt;of this surgical procedure.&lt;/p&gt;</abstract>
			<keyword_fa></keyword_fa>
			<keyword>One-and-a-half-ventricle repair, Right-tricular venhypoplasia, Right-ventricular dysfunction.</keyword>
			<start_page>0</start_page>
			<end_page>0</end_page>
			<web_url>http://www.iscs.org.ir/journals/vol.3/no.2/328/</web_url>
			<author_list>
				
			</author_list>
		</article>
		
		<article>
			<language></language>
			<article_id_issn></article_id_issn>
			<article_id_issn_online></article_id_issn_online>
			<article_id_pubmed></article_id_pubmed>
			<article_id_pii></article_id_pii>
			<article_id_doi></article_id_doi>
			<article_id_iranmedex></article_id_iranmedex>
			<article_id_magiran></article_id_magiran>
			<article_id_sid></article_id_sid>
			<title_fa></title_fa>
			<title>Outcomes of Surgery for Simple Total Anomalous Pulmonary Venous Drainage in Neonates</title>
			<subject_fa></subject_fa>
			<subject></subject>
			<content_type_fa></content_type_fa>
			<content_type>Review</content_type>
			<abstract_fa></abstract_fa>
			<abstract>&lt;p&gt;Repair of total anomalous pulmonary venous&lt;br /&gt;drainage (TAPVD) in neonates remains a challenge as it-is often associated with severe obstruction. We describe a&lt;br /&gt;large cohort of neonates who underwent TAPVD repair ata single institution.&lt;/p&gt;</abstract>
			<keyword_fa></keyword_fa>
			<keyword>-</keyword>
			<start_page>0</start_page>
			<end_page>0</end_page>
			<web_url>http://www.iscs.org.ir/journals/vol.3/no.2/327/</web_url>
			<author_list>
				
			</author_list>
		</article>
		
		<article>
			<language></language>
			<article_id_issn></article_id_issn>
			<article_id_issn_online></article_id_issn_online>
			<article_id_pubmed></article_id_pubmed>
			<article_id_pii></article_id_pii>
			<article_id_doi></article_id_doi>
			<article_id_iranmedex></article_id_iranmedex>
			<article_id_magiran></article_id_magiran>
			<article_id_sid></article_id_sid>
			<title_fa></title_fa>
			<title>Tranexamic acid versus-aminocaproic acid: efficacy and safety in paediatric cardiac surgery</title>
			<subject_fa></subject_fa>
			<subject></subject>
			<content_type_fa></content_type_fa>
			<content_type>Review</content_type>
			<abstract_fa></abstract_fa>
			<abstract>&lt;p&gt;Tranexamic acid (TXA) and -aminocaproic acid&lt;br /&gt;(EACA) are used for antifibrinolytic therapy in cardiac surgery,&lt;br /&gt;although data directly comparing their blood sparing&lt;br /&gt;effect and their side effects, especially in paediatric cardiac&lt;br /&gt;surgical patients, are still missing.&lt;/p&gt;</abstract>
			<keyword_fa></keyword_fa>
			<keyword>Tranexamic acid, Aminocaproic acid, Paedi-atric cardiac surgery, Blood loss, Outcome.</keyword>
			<start_page>0</start_page>
			<end_page>0</end_page>
			<web_url>http://www.iscs.org.ir/journals/vol.3/no.2/326/</web_url>
			<author_list>
				
			</author_list>
		</article>
		
		<article>
			<language></language>
			<article_id_issn></article_id_issn>
			<article_id_issn_online></article_id_issn_online>
			<article_id_pubmed></article_id_pubmed>
			<article_id_pii></article_id_pii>
			<article_id_doi></article_id_doi>
			<article_id_iranmedex></article_id_iranmedex>
			<article_id_magiran></article_id_magiran>
			<article_id_sid></article_id_sid>
			<title_fa></title_fa>
			<title>Is it safe to perform coronary angiography during acute endocarditis?</title>
			<subject_fa></subject_fa>
			<subject></subject>
			<content_type_fa></content_type_fa>
			<content_type>Review</content_type>
			<abstract_fa></abstract_fa>
			<abstract>&lt;p&gt;A best evidence topic was written according to a structured&lt;br /&gt;protocol. The question addressed was &#39;Is it safe to perform&lt;br /&gt;coronary angiography (CA) in acute endocarditis?&#39; Three&lt;br /&gt;hundred and ninety-seven papers were found using the reported&lt;br /&gt;search, of which six represented the best evidence to&lt;br /&gt;answer the clinical question. The authors, journal, date and&lt;br /&gt;country of publication, patient group studied, study type,&lt;br /&gt;relevant outcomes, key results and limitations of these pa-are tabulated. One of the papers is a case report, which&lt;br /&gt;reported a fatal vegetation embolism from an infected aortic&lt;br /&gt;valve into the left main coronary artery 14 h after angiography.&lt;br /&gt;The remaining five papers are cohort studies. Four&lt;br /&gt;of these studies were performed in 1970s-1980s before&lt;br /&gt;the era of echocardiography and were aimed at quantifying&lt;br /&gt;the severity of valvular regurgitation. No embolic complications&lt;br /&gt;or dislodgement of vegetations occurred in any&lt;br /&gt;of the five studies (186 patients). Guidelines published bythe European Society of Cardiology (ESC) in 2009 recommended&lt;br /&gt;CA in the context of infective endocarditis (IE) for&lt;br /&gt;men &amp;gt;40 years old, postmenopausal women, and patients&lt;br /&gt;with at least one cardiovascular risk factor or a history of&lt;br /&gt;coronary artery disease. Exceptions include patients with&lt;br /&gt;large aortic vegetations which may be dislodged during&lt;br /&gt;catheterisation, and when emergency surgery is necessary&lt;br /&gt;- 1) native aortic or mitral IE with severe acute regurgitation&lt;br /&gt;or valve obstruction, or prosthetic valve IE with severe&lt;br /&gt;prosthetic dysfunction (dehiscence or obstruction) causing&lt;br /&gt;refractory pulmonary oedema or cardiogenic shock; 2) native&lt;br /&gt;aortic, mitral, or prosthetic valve IE with fistula into a cardiac chamber or pericardium causing refractory pulmonary&lt;br /&gt;oedema or shock. This is reiterated by the guidelines&lt;br /&gt;on the management of valvular heart disease published by&lt;br /&gt;the ESC in 2007. From the findings of the six papers, it can&lt;br /&gt;be concluded that coronary angiography can be performed&lt;br /&gt;safely in IE and should be performed if deemed necessary,&lt;br /&gt;unless the patients are haemodynamically unstable requiring&lt;br /&gt;emergency surgery, or have large vegetations of the&lt;br /&gt;aortic valve. This is consistent with the ESC guidelines.&lt;/p&gt;</abstract>
			<keyword_fa></keyword_fa>
			<keyword>Coronary angiography; Infective endocardi-tisSafety</keyword>
			<start_page>0</start_page>
			<end_page>0</end_page>
			<web_url>http://www.iscs.org.ir/journals/vol.3/no.2/325/</web_url>
			<author_list>
				
			</author_list>
		</article>
		
		<article>
			<language></language>
			<article_id_issn></article_id_issn>
			<article_id_issn_online></article_id_issn_online>
			<article_id_pubmed></article_id_pubmed>
			<article_id_pii></article_id_pii>
			<article_id_doi></article_id_doi>
			<article_id_iranmedex></article_id_iranmedex>
			<article_id_magiran></article_id_magiran>
			<article_id_sid></article_id_sid>
			<title_fa></title_fa>
			<title>Off-Pump and On-Pump Coronary Artery Bypass Grafting Are Associated With SimilarGraft Patency, Myocardial Ischemia, and Freedom From Reintervention: Long-Term Follow-Up of a Randomized Trial</title>
			<subject_fa></subject_fa>
			<subject></subject>
			<content_type_fa></content_type_fa>
			<content_type>Review</content_type>
			<abstract_fa></abstract_fa>
			<abstract>&lt;p&gt;The Surgical Management of Arterial Revascularization&lt;br /&gt;Therapies trial was conceived to rigorously&lt;br /&gt;compare completeness of revascularization, clinical outcomes&lt;br /&gt;and resource utilization in unselected patients referred&lt;br /&gt;for elective, primary coronary artery bypass grafting&lt;br /&gt;randomly assigned to undergo off-pump (OPCAB) or conventional&lt;br /&gt;on-pump coronary artery bypass grafting using&lt;br /&gt;cardiopulmonary bypass (CPB). The goal of this follow-up&lt;br /&gt;study was to compare long-term survival, graft patency,&lt;br /&gt;myocardial ischemia, and clinical outcomes among survivors&lt;br /&gt;who volunteered to return for clinical evaluation and&lt;br /&gt;imaging studies.&lt;/p&gt;</abstract>
			<keyword_fa></keyword_fa>
			<keyword>-</keyword>
			<start_page>0</start_page>
			<end_page>0</end_page>
			<web_url>http://www.iscs.org.ir/journals/vol.3/no.2/324/</web_url>
			<author_list>
				
			</author_list>
		</article>
		
		<article>
			<language></language>
			<article_id_issn></article_id_issn>
			<article_id_issn_online></article_id_issn_online>
			<article_id_pubmed></article_id_pubmed>
			<article_id_pii></article_id_pii>
			<article_id_doi></article_id_doi>
			<article_id_iranmedex></article_id_iranmedex>
			<article_id_magiran></article_id_magiran>
			<article_id_sid></article_id_sid>
			<title_fa></title_fa>
			<title>Ablation of Atrial Fibrillation: Comparison of Catheter-Based Techniques and the Cox-Maze III Operation</title>
			<subject_fa></subject_fa>
			<subject></subject>
			<content_type_fa></content_type_fa>
			<content_type>Review</content_type>
			<abstract_fa></abstract_fa>
			<abstract>&lt;p&gt;Catheter-based ablation is often recommended&lt;br /&gt;for treatment of atrial fibrillation (AF), but there are no&lt;br /&gt;data that directly compare late results to those of the Cox-&lt;br /&gt;Maze procedure. Although catheter ablation avoids operation,&lt;br /&gt;lack of reliable transmurality may reduce effectiveness.&lt;br /&gt;We compared clinical outcomes of the cut-and-sew&lt;br /&gt;Cox-Maze procedure with catheter ablation.&lt;/p&gt;</abstract>
			<keyword_fa></keyword_fa>
			<keyword>-</keyword>
			<start_page>0</start_page>
			<end_page>0</end_page>
			<web_url>http://www.iscs.org.ir/journals/vol.3/no.2/323/</web_url>
			<author_list>
				
			</author_list>
		</article>
		
		<article>
			<language></language>
			<article_id_issn></article_id_issn>
			<article_id_issn_online></article_id_issn_online>
			<article_id_pubmed></article_id_pubmed>
			<article_id_pii></article_id_pii>
			<article_id_doi></article_id_doi>
			<article_id_iranmedex></article_id_iranmedex>
			<article_id_magiran></article_id_magiran>
			<article_id_sid></article_id_sid>
			<title_fa></title_fa>
			<title>Up to 6-year follow-up after pulmonary vein isolation for persistent/permanent atrialfibrillation: Importance of sinus node function</title>
			<subject_fa></subject_fa>
			<subject></subject>
			<content_type_fa></content_type_fa>
			<content_type>Review</content_type>
			<abstract_fa></abstract_fa>
			<abstract>&lt;p&gt;Sinus node dysfunction is commonly associated&lt;br /&gt;with atrial fibrillation. There is little information about the&lt;br /&gt;long-term results of pulmonary vein isolation in relation to&lt;br /&gt;sinus node function. The present study was conducted to&lt;br /&gt;investigate whether sinus node dysfunction affects the late&lt;br /&gt;outcome of pulmonary vein isolation in patients with persistent/&lt;br /&gt;permanent atrial fibrillation.&lt;/p&gt;</abstract>
			<keyword_fa></keyword_fa>
			<keyword>-</keyword>
			<start_page>0</start_page>
			<end_page>0</end_page>
			<web_url>http://www.iscs.org.ir/journals/vol.3/no.2/322/</web_url>
			<author_list>
				
			</author_list>
		</article>
		
		<article>
			<language></language>
			<article_id_issn></article_id_issn>
			<article_id_issn_online></article_id_issn_online>
			<article_id_pubmed></article_id_pubmed>
			<article_id_pii></article_id_pii>
			<article_id_doi></article_id_doi>
			<article_id_iranmedex></article_id_iranmedex>
			<article_id_magiran></article_id_magiran>
			<article_id_sid></article_id_sid>
			<title_fa></title_fa>
			<title>Antegrade Cerebral Perfusion With Mild Hypothermia for Aortic Arch Replacement:Single-Center Experience in 245 Consecutive Patients</title>
			<subject_fa></subject_fa>
			<subject></subject>
			<content_type_fa></content_type_fa>
			<content_type>Review</content_type>
			<abstract_fa></abstract_fa>
			<abstract>&lt;p&gt;Aortic arch replacement remains a surgical&lt;br /&gt;challenge because of prolonged operative times, bleeding&lt;br /&gt;complications, and a considerable risk of neurologic morbidity&lt;br /&gt;and mortality. This study investigates our clinical&lt;br /&gt;results after modification of perfusion technique for cardiopulmonary&lt;br /&gt;bypass as well as temperature management for&lt;br /&gt;these high- risk patients.&lt;/p&gt;</abstract>
			<keyword_fa></keyword_fa>
			<keyword>-</keyword>
			<start_page>0</start_page>
			<end_page>0</end_page>
			<web_url>http://www.iscs.org.ir/journals/vol.3/no.2/321/</web_url>
			<author_list>
				
			</author_list>
		</article>
		
		<article>
			<language></language>
			<article_id_issn></article_id_issn>
			<article_id_issn_online></article_id_issn_online>
			<article_id_pubmed></article_id_pubmed>
			<article_id_pii></article_id_pii>
			<article_id_doi></article_id_doi>
			<article_id_iranmedex></article_id_iranmedex>
			<article_id_magiran></article_id_magiran>
			<article_id_sid></article_id_sid>
			<title_fa></title_fa>
			<title>Acute type A aortic dissection and pregnancy: a population-based study</title>
			<subject_fa></subject_fa>
			<subject></subject>
			<content_type_fa></content_type_fa>
			<content_type>Review</content_type>
			<abstract_fa></abstract_fa>
			<abstract>&lt;p&gt;Pregnancy has been reported to be an independent&lt;br /&gt;risk factor for 50% of acute aortic dissections recorded&lt;br /&gt;in women younger than 45 years of age. The present epidemiologic&lt;br /&gt;study aimed to identify whether this putative&lt;br /&gt;association of pregnancy and acute type A dissection could&lt;br /&gt;be an artifact of selective reporting.&lt;/p&gt;</abstract>
			<keyword_fa></keyword_fa>
			<keyword>Aorta, Aortic dissection, Pregnancy, Prognosis.</keyword>
			<start_page>0</start_page>
			<end_page>0</end_page>
			<web_url>http://www.iscs.org.ir/journals/vol.3/no.2/320/</web_url>
			<author_list>
				
			</author_list>
		</article>
		
		<article>
			<language></language>
			<article_id_issn></article_id_issn>
			<article_id_issn_online></article_id_issn_online>
			<article_id_pubmed></article_id_pubmed>
			<article_id_pii></article_id_pii>
			<article_id_doi></article_id_doi>
			<article_id_iranmedex></article_id_iranmedex>
			<article_id_magiran></article_id_magiran>
			<article_id_sid></article_id_sid>
			<title_fa></title_fa>
			<title>Extracorporeal membrane oxygenation for acute respiratory distress syndrome: is theconfiguration mode an important predictor for the outcome?</title>
			<subject_fa></subject_fa>
			<subject></subject>
			<content_type_fa></content_type_fa>
			<content_type>Review</content_type>
			<abstract_fa></abstract_fa>
			<abstract>&lt;p&gt;Extracorporeal membrane oxygenation (ECMO) is increasingly&lt;br /&gt;applied as rescue-therapy for patients with severe&lt;br /&gt;acute respiratory distress syndrome (ARDS). Here,&lt;br /&gt;we evaluate the effect of different configuration strategies&lt;br /&gt;(venovenous vs. venoarterial vs. veno-venoarterial) on the&lt;br /&gt;outcome. From 2006 to 2008, 30 patients received ECMO&lt;br /&gt;for severe ARDS. Patients were divided into three groups&lt;br /&gt;according to the configuration: veno-venous (vv; n=11),&lt;br /&gt;venoarterial (va; n=8) or veno-venoarterial (vva; n=11).&lt;br /&gt;Data were prospectively collected and endpoint was 30-day&lt;br /&gt;mortality. To identify independent risk factors, univariate&lt;br /&gt;analysis was performed for clinical parameters, such as&lt;br /&gt;age, body mass index, gender, configuration, low-pH, oxygenation&lt;br /&gt;index (pO2/FiO2) and underlying disease. Thirty- mortality was 53% (n=16) for all comers: 63% (n=7)&lt;br /&gt;died in the vv-group, 75% (n=6) in the va-group and 27%&lt;br /&gt;(n=3) in the vva-group. Although univariate analysis could&lt;br /&gt;not rule out a significant predictor for the outcome, there&lt;br /&gt;was a trend visible to decreased mortality in the vva-group&lt;br /&gt;when compared to vv- and va-groups (27% vs. 63% vs.&lt;br /&gt;75%; P=0.057). ECMO provides a survival benefit in patients&lt;br /&gt;when considering a predicted mortality rate of 80% in&lt;br /&gt;ARDS. The configuration mode appears to impact the outcome&lt;br /&gt;as the veno-venoarterial appears to further improve&lt;br /&gt;the survival in this subset of patients.&lt;/p&gt;</abstract>
			<keyword_fa></keyword_fa>
			<keyword>Extracorporeal membrane oxygenation; Acute respiratory distress syndrome; Configuration mode.</keyword>
			<start_page>0</start_page>
			<end_page>0</end_page>
			<web_url>http://www.iscs.org.ir/journals/vol.3/no.2/319/</web_url>
			<author_list>
				
			</author_list>
		</article>
		
		<article>
			<language></language>
			<article_id_issn></article_id_issn>
			<article_id_issn_online></article_id_issn_online>
			<article_id_pubmed></article_id_pubmed>
			<article_id_pii></article_id_pii>
			<article_id_doi></article_id_doi>
			<article_id_iranmedex></article_id_iranmedex>
			<article_id_magiran></article_id_magiran>
			<article_id_sid></article_id_sid>
			<title_fa></title_fa>
			<title>Alternative approaches for trans-catheter self-expanding aortic bioprosthetic valvesimplantation: single-center experience</title>
			<subject_fa></subject_fa>
			<subject></subject>
			<content_type_fa></content_type_fa>
			<content_type>Review</content_type>
			<abstract_fa></abstract_fa>
			<abstract>&lt;p&gt;Trans-catheter aortic valve implantation has&lt;br /&gt;emerged and rapidly gained credibility as a valuable alternative&lt;br /&gt;to treat patients with severe aortic stenosis and no surgical&lt;br /&gt;option; however, these patients are often affected also by&lt;br /&gt;severe iliac-femoral arteriopathy, rendering the transfemoral&lt;br /&gt;approach unemployable. From May 2008, 92 patients with&lt;br /&gt;severe, symptomatic aortic stenosis and no reasonable surgical&lt;br /&gt;option because of excessive risk underwent trans-catheter&lt;br /&gt;aortic valve implantation at our center. Eighty patients (34&lt;br /&gt;male) with mean age 82 &amp;plusmn; 8 years were eligible for Core-&lt;br /&gt;Valve percutaneous femoral implantation. Twelve patients,&lt;br /&gt;mean age 81 &amp;plusmn; 8 years, were excluded from percutaneous&lt;br /&gt;femoral CoreValve implantation because of iliac-femoral arteriopathy.&lt;/p&gt;</abstract>
			<keyword_fa></keyword_fa>
			<keyword>Aortic stenosis • Trans-catheter valve replace-ment Axillary artery • Aortic valve.</keyword>
			<start_page>0</start_page>
			<end_page>0</end_page>
			<web_url>http://www.iscs.org.ir/journals/vol.3/no.2/318/</web_url>
			<author_list>
				
			</author_list>
		</article>
		
		<article>
			<language></language>
			<article_id_issn></article_id_issn>
			<article_id_issn_online></article_id_issn_online>
			<article_id_pubmed></article_id_pubmed>
			<article_id_pii></article_id_pii>
			<article_id_doi></article_id_doi>
			<article_id_iranmedex></article_id_iranmedex>
			<article_id_magiran></article_id_magiran>
			<article_id_sid></article_id_sid>
			<title_fa></title_fa>
			<title>Intracoronary levosimendan prevents myocardial ischemic damages and activates sur-vival signaling through ATP-sensitive potassium channel and nitric oxide</title>
			<subject_fa></subject_fa>
			<subject></subject>
			<content_type_fa></content_type_fa>
			<content_type>Review</content_type>
			<abstract_fa></abstract_fa>
			<abstract>&lt;p&gt;Levosimendan has been reported to exert cardioprotection.&lt;br /&gt;In this study, we have examined the cardiac&lt;br /&gt;effects of different doses of intracoronary levosimendan on&lt;br /&gt;ischemia/reperfusion injuries, and the involvement of KATP&lt;br /&gt;channels and nitric oxide (NO).&lt;/p&gt;</abstract>
			<keyword_fa></keyword_fa>
			<keyword>Akt, Apoptosis, ERK, Levosimendan, NO,Potassium channels.</keyword>
			<start_page>0</start_page>
			<end_page>0</end_page>
			<web_url>http://www.iscs.org.ir/journals/vol.3/no.2/317/</web_url>
			<author_list>
				
			</author_list>
		</article>
		
		<article>
			<language></language>
			<article_id_issn></article_id_issn>
			<article_id_issn_online></article_id_issn_online>
			<article_id_pubmed></article_id_pubmed>
			<article_id_pii></article_id_pii>
			<article_id_doi></article_id_doi>
			<article_id_iranmedex></article_id_iranmedex>
			<article_id_magiran></article_id_magiran>
			<article_id_sid></article_id_sid>
			<title_fa></title_fa>
			<title>Prolonged time between donor brain death and organ retrieval results in an increasedrisk of mortality in cardiac transplant recipients</title>
			<subject_fa></subject_fa>
			<subject></subject>
			<content_type_fa></content_type_fa>
			<content_type>Review</content_type>
			<abstract_fa></abstract_fa>
			<abstract>&lt;p&gt;In cardiac transplantation longer ischemic times relate to poorer&lt;br /&gt;outcomes. However, brain death also promotes donor organ&lt;br /&gt;injury. The aim of this study was to ascertain if there was an&lt;br /&gt;association between longer time periods between donor brain&lt;br /&gt;death and organ retrieval with recipient mortality. This retrospective&lt;br /&gt;single centre study included 157 cardiac transplants&lt;br /&gt;performed between February 1999 and 2009. The time between&lt;br /&gt;the second brain stem death test and the cross-clamp&lt;br /&gt;time at organ retrieval was noted in hours. This was compared&lt;br /&gt;with survival time in years. Cox regression analysis was performed.&lt;br /&gt;The following variables were included: donor and recipient&lt;br /&gt;sex, age and cytomegalovirus status; donor smokinghistory; ischemic time and number of rejection episodes. Of&lt;br /&gt;the 157 transplants, 37 recipients have died. The mean followup&lt;br /&gt;was 4.1 years. The mean time between brain stem death test&lt;br /&gt;and cross-clamp time was 13.2&amp;plusmn;3.96 hours. Considering the&lt;br /&gt;above variables, the most significant finding is: increased time&lt;br /&gt;between brain stem death test and organ retrieval cross-clamp&lt;br /&gt;time, predicted a greater recipient mortality [HR=1.15; 95%&lt;br /&gt;confidence interval (CI)=1.06-1.24; P&amp;lt;0.001]. Longer delays&lt;br /&gt;between donor brain death and cross-clamp time are associated&lt;br /&gt;with a higher-risk of mortality in cardiac transplant recipients.&lt;/p&gt;</abstract>
			<keyword_fa></keyword_fa>
			<keyword>Brain death; Donor and heart transplant</keyword>
			<start_page>0</start_page>
			<end_page>0</end_page>
			<web_url>http://www.iscs.org.ir/journals/vol.3/no.2/316/</web_url>
			<author_list>
				
			</author_list>
		</article>
		
		<article>
			<language></language>
			<article_id_issn></article_id_issn>
			<article_id_issn_online></article_id_issn_online>
			<article_id_pubmed></article_id_pubmed>
			<article_id_pii></article_id_pii>
			<article_id_doi></article_id_doi>
			<article_id_iranmedex></article_id_iranmedex>
			<article_id_magiran></article_id_magiran>
			<article_id_sid></article_id_sid>
			<title_fa></title_fa>
			<title>Pediatric heart transplantation: 23-year single-center experience</title>
			<subject_fa></subject_fa>
			<subject></subject>
			<content_type_fa></content_type_fa>
			<content_type>Review</content_type>
			<abstract_fa></abstract_fa>
			<abstract>&lt;p&gt;Early and late mortality have significantly improved&lt;br /&gt;during recent decades in pediatric patients after heart&lt;br /&gt;transplantation (HTx). Nevertheless early and late morbidity&lt;br /&gt;and mortality are influenced by acute rejection, cardiac&lt;br /&gt;allograft vasculopathy (CAV), malignancy, renal failure,&lt;br /&gt;and graft failure. Methods: We evaluated our results after&lt;br /&gt;HTx in children under the age of 18 years with 23 years of&lt;br /&gt;follow-up. Perioperative characteristics, probability of survival,&lt;br /&gt;and time-related morbidity were retrospectively analyzed.&lt;br /&gt;Results: We included 169 pediatric HTx recipients,&lt;br /&gt;transplanted between 05/1986 and 05/2010. One hundred&lt;br /&gt;and one were males with a median age of 8.7 (0.02-23.2)&lt;br /&gt;years at the time of HTx. Main preoperative diagnoses were&lt;br /&gt;cardiomyopathy (CMP) (n = 139) with a median survival of&lt;br /&gt;7.0 (0-23.2) years and congenital heart disease (CHD) (n =&lt;br /&gt;30), median survival 11.3 (0-19.9) years. Overall survival&lt;br /&gt;at 1, 5, 10, and 15 years was 87%, 76%, 68%, and 50%,&lt;br /&gt;respectively. Patient survival was significantly reduced&lt;br /&gt;in patients with 0-1 year at the time of HTx versus 1-10&lt;br /&gt;and 11-18 years: 2.3 (0-13.2) years versus 1-10 years =&lt;br /&gt;8.6 (0-23.2) years; 11-18 years = 5.9 (0.003-18.5) years.&lt;br /&gt;Fifty-one patients were on mechanical circulatory support&lt;br /&gt;as a bridge-to-HTx with increased early but not late mortality.&lt;br /&gt;Ten patients underwent retransplant due to acute or&lt;br /&gt;chronic graft failure after a median posttransplant time of&lt;br /&gt;12.25 (0.3-17.45) years. Late mortality was influenced by&lt;br /&gt;rejection, infection, posttransplant lymphoproliferative disease&lt;br /&gt;(PTLD) (11.8%), or CAV with an incidence of 25%&lt;br /&gt;at 5 years, 50% at 10 years, and approximately 75% at 15&lt;br /&gt;years. Conclusions: Pediatric HTx is a safe and effective&lt;br /&gt;treatment for terminal heart failure. In our experience, there&lt;br /&gt;is no adverse effect of previous cardiac assist device implantation&lt;br /&gt;in long-term follow-up. Virtually all anatomic&lt;br /&gt;malformations are amenable to orthotopic HTx. Significant&lt;br /&gt;progress has been achieved in controlling rejection through&lt;br /&gt;improved immunosuppression and noninvasive rejection&lt;br /&gt;monitoring.&lt;/p&gt;</abstract>
			<keyword_fa></keyword_fa>
			<keyword>Heart transplantation, Pediatric, Cardiacallograft vasculopathy, Acute rejection, PTLD, Survival,23 years.</keyword>
			<start_page>0</start_page>
			<end_page>0</end_page>
			<web_url>http://www.iscs.org.ir/journals/vol.3/no.2/315/</web_url>
			<author_list>
				
			</author_list>
		</article>
		
		<article>
			<language></language>
			<article_id_issn></article_id_issn>
			<article_id_issn_online></article_id_issn_online>
			<article_id_pubmed></article_id_pubmed>
			<article_id_pii></article_id_pii>
			<article_id_doi></article_id_doi>
			<article_id_iranmedex></article_id_iranmedex>
			<article_id_magiran></article_id_magiran>
			<article_id_sid></article_id_sid>
			<title_fa></title_fa>
			<title>Prevalence of periodontitis and optimal timing of dental treatment in patientsundergoing heart valve surgery</title>
			<subject_fa></subject_fa>
			<subject></subject>
			<content_type_fa></content_type_fa>
			<content_type>Review</content_type>
			<abstract_fa></abstract_fa>
			<abstract>&lt;p&gt;We investigated the prevalence, risk factors, and optimal&lt;br /&gt;timing of treatment for advanced periodontitis in patients&lt;br /&gt;undergoing elective heart valve surgery. Dental examinations&lt;br /&gt;were given to 209 patients (aged 65&amp;plusmn;10 years)&lt;br /&gt;scheduled for valve surgery. Patients with no or mild periodontitis&lt;br /&gt;were assigned as controls (n=105). Patients with&lt;br /&gt;advanced periodontitis underwent tooth extraction and curettage&lt;br /&gt;(n=104), 68 of whom underwent tooth extraction&lt;br /&gt;within two weeks (short wait) and 36 of whom underwent&lt;br /&gt;extraction longer than two weeks, before surgery. The three&lt;br /&gt;groups (control, short, and long wait) were similar in age,&lt;br /&gt;gender, diseased valve, and type of surgery received. The&lt;br /&gt;average number of teeth extracted was 2.3&amp;plusmn;2.3. In both univariate&lt;br /&gt;and multivariate analysis, risk factors for advancedperiodontitis were history of smoking and heart failure. No&lt;br /&gt;complications arose from the extractions. Length of postoperative&lt;br /&gt;hospital stay, intrafebrile days, white blood cell&lt;br /&gt;count and serum C-reactive protein (assessed at postoperative&lt;br /&gt;days 1, 3 and 7) were similar among the three groups.&lt;br /&gt;During the mean follow-up period of 60&amp;plusmn;16 months, no&lt;br /&gt;patient developed prosthetic valve endocarditis, and there&lt;br /&gt;were no postoperative deaths. In conclusion, we found no&lt;br /&gt;evidence that receipt and timing of dental treatment affected&lt;br /&gt;surgical success rates and postoperative course.&lt;/p&gt;</abstract>
			<keyword_fa></keyword_fa>
			<keyword>Heart valve; Endocarditis; Perioperative care; Infection</keyword>
			<start_page>0</start_page>
			<end_page>0</end_page>
			<web_url>http://www.iscs.org.ir/journals/vol.3/no.2/314/</web_url>
			<author_list>
				
			</author_list>
		</article>
		
		<article>
			<language></language>
			<article_id_issn></article_id_issn>
			<article_id_issn_online></article_id_issn_online>
			<article_id_pubmed></article_id_pubmed>
			<article_id_pii></article_id_pii>
			<article_id_doi></article_id_doi>
			<article_id_iranmedex></article_id_iranmedex>
			<article_id_magiran></article_id_magiran>
			<article_id_sid></article_id_sid>
			<title_fa></title_fa>
			<title>High-dose tranexamic acid is related to increased risk of generalized seizures afteraortic valve replacement</title>
			<subject_fa></subject_fa>
			<subject></subject>
			<content_type_fa></content_type_fa>
			<content_type>Review</content_type>
			<abstract_fa></abstract_fa>
			<abstract>&lt;p&gt;To investigate the incidence of postoperative&lt;br /&gt;generalized seizures in patients undergoing aortic valve&lt;br /&gt;replacement (AVR) under extracorporeal circulation, who&lt;br /&gt;received either high-dose tranexamic acid (TXA) or epsilon&lt;br /&gt;aminocaproic acid (EACA) as an antifibrinolytic agent.&lt;/p&gt;</abstract>
			<keyword_fa></keyword_fa>
			<keyword>Antifibrinolytic agent , Aortic valve replace-mentSeizure , Tranexamic acid</keyword>
			<start_page>0</start_page>
			<end_page>0</end_page>
			<web_url>http://www.iscs.org.ir/journals/vol.3/no.2/313/</web_url>
			<author_list>
				
			</author_list>
		</article>
		
		<article>
			<language></language>
			<article_id_issn></article_id_issn>
			<article_id_issn_online></article_id_issn_online>
			<article_id_pubmed></article_id_pubmed>
			<article_id_pii></article_id_pii>
			<article_id_doi></article_id_doi>
			<article_id_iranmedex></article_id_iranmedex>
			<article_id_magiran></article_id_magiran>
			<article_id_sid></article_id_sid>
			<title_fa></title_fa>
			<title>Aortic valve-sparing operations in aortic root aneurysms: remodeling orreimplantation?</title>
			<subject_fa></subject_fa>
			<subject></subject>
			<content_type_fa></content_type_fa>
			<content_type>Review</content_type>
			<abstract_fa></abstract_fa>
			<abstract>&lt;p&gt;A best evidence topic was written according to a structured&lt;br /&gt;protocol. The question addressed was whether the reimplantation&lt;br /&gt;(David) technique or the remodeling (Yacoub)&lt;br /&gt;technique provides the optimum event free survival in patients&lt;br /&gt;with an aortic root aneurysm suitable for an aortic&lt;br /&gt;valve-sparing operation. In total, 392 papers were found&lt;br /&gt;using the reported search criteria, of which 14 papers proprovided&lt;br /&gt;the best evidence to answer the clinical question. A&lt;br /&gt;total of 1338 patients (Yacoub technique in 606 and David&lt;br /&gt;technique in 732) from 13 centres were included. In most&lt;br /&gt;series, cardiopulmonary bypass time and aortic cross-clamp&lt;br /&gt;time were longer for the David technique compared to the&lt;br /&gt;Yacoub technique. Early mortality was comparable between&lt;br /&gt;the two techniques (0-6.9% for the Yacoub technique&lt;br /&gt;and 0-6% for the David technique). There is a tendency fora higher freedom from significant long-term aortic insufficiency&lt;br /&gt;in the David group than the Yacoub group, which&lt;br /&gt;does not necessarily result in a higher reoperation rate in&lt;br /&gt;the Yacoub group. In the largest series reported by David et&lt;br /&gt;al., freedom from a moderate-to-severe aortic insufficiency&lt;br /&gt;at 12 years was 82.6&amp;plusmn;6.2% in the Yacoub and 91.0&amp;plusmn;3.8%&lt;br /&gt;in the David group (P=0.035). Freedom from reoperation&lt;br /&gt;at the same time point was 90.4&amp;plusmn;4.7% in the Yacoub group&lt;br /&gt;and 97.4&amp;plusmn;2.2% in the David group (P=0.09). In another series&lt;br /&gt;reported by Erasmi et al., freedom from reoperation at&lt;br /&gt;a follow-up time of about four years was 89&amp;plusmn;4% in the Yacoubauthors merely preferred the Yacoub technique for a bicuspid&lt;br /&gt;aortic valve, the accumulated evidence in the current&lt;br /&gt;review indicates comparable results for both techniques in&lt;br /&gt;a bicuspid aortic valve. Current evidence is in favour of the&lt;br /&gt;David rather than the Yacoub technique in pathologies such&lt;br /&gt;as Marfan syndrome, acute type A aortic dissection, and&lt;br /&gt;excessive annular dilatation that may impair aortic root integrity.&lt;br /&gt;Careful selection of patients for each technique and&lt;br /&gt;successful restoration of normal cusp geometry are the keys&lt;br /&gt;to success in aortic valve-sparing operations. Keywords:&lt;br /&gt;Aortic valve-sparing operation; Remodeling; Reimplantation;&lt;br /&gt;Aortic root aneurysm&lt;br /&gt;group and 98&amp;plusmn;2% in the David group. Although some&lt;/p&gt;</abstract>
			<keyword_fa></keyword_fa>
			<keyword>-</keyword>
			<start_page>0</start_page>
			<end_page>0</end_page>
			<web_url>http://www.iscs.org.ir/journals/vol.3/no.2/312/</web_url>
			<author_list>
				
			</author_list>
		</article>
		
		<article>
			<language></language>
			<article_id_issn></article_id_issn>
			<article_id_issn_online></article_id_issn_online>
			<article_id_pubmed></article_id_pubmed>
			<article_id_pii></article_id_pii>
			<article_id_doi></article_id_doi>
			<article_id_iranmedex></article_id_iranmedex>
			<article_id_magiran></article_id_magiran>
			<article_id_sid></article_id_sid>
			<title_fa></title_fa>
			<title>Tricuspid annuloplasty prevents right ventricular dilatation and progression oftricuspid regurgitation in patients with tricuspid annular dilatation undergoingmitral valve repair</title>
			<subject_fa></subject_fa>
			<subject></subject>
			<content_type_fa></content_type_fa>
			<content_type>Review</content_type>
			<abstract_fa></abstract_fa>
			<abstract>&lt;p&gt;We hypothesize that concomitant tricuspid annuloplasty&lt;br /&gt;in patients with tricuspid annular dilatation who&lt;br /&gt;undergo mitral valve repair could prevent progression of&lt;br /&gt;tricuspid regurgitation and right ventricular remodeling.&lt;/p&gt;</abstract>
			<keyword_fa></keyword_fa>
			<keyword>-</keyword>
			<start_page>0</start_page>
			<end_page>0</end_page>
			<web_url>http://www.iscs.org.ir/journals/vol.3/no.2/311/</web_url>
			<author_list>
				
			</author_list>
		</article>
		
		<article>
			<language></language>
			<article_id_issn></article_id_issn>
			<article_id_issn_online></article_id_issn_online>
			<article_id_pubmed></article_id_pubmed>
			<article_id_pii></article_id_pii>
			<article_id_doi></article_id_doi>
			<article_id_iranmedex></article_id_iranmedex>
			<article_id_magiran></article_id_magiran>
			<article_id_sid></article_id_sid>
			<title_fa></title_fa>
			<title>Analysis of Different Aspects of DelayedSternal Closure in Pediatrics and Adults:A Review</title>
			<subject_fa></subject_fa>
			<subject></subject>
			<content_type_fa></content_type_fa>
			<content_type>Review</content_type>
			<abstract_fa></abstract_fa>
			<abstract>&lt;p&gt;Delayed sternal closure (DSC) has been shown to be useful following&lt;br /&gt;cardiac surgeries in case of indications including hemodynamic instability, noticeable&lt;br /&gt;myocardial edema, respiratory compromise, stubborn bleeding, placement of extracorporeal&lt;br /&gt;support device,and persistent arrhythmias. In this review, we summarize the&lt;br /&gt;investigations on this topic to analyze the controversial aspects of DSC in pediatrics&lt;br /&gt;and adults.&lt;/p&gt;</abstract>
			<keyword_fa></keyword_fa>
			<keyword>-</keyword>
			<start_page>34</start_page>
			<end_page>45</end_page>
			<web_url>http://www.iscs.org.ir/journals/vol.3/no.2/310/</web_url>
			<author_list>
				
			</author_list>
		</article>
		
		<article>
			<language></language>
			<article_id_issn></article_id_issn>
			<article_id_issn_online></article_id_issn_online>
			<article_id_pubmed></article_id_pubmed>
			<article_id_pii></article_id_pii>
			<article_id_doi></article_id_doi>
			<article_id_iranmedex></article_id_iranmedex>
			<article_id_magiran></article_id_magiran>
			<article_id_sid></article_id_sid>
			<title_fa></title_fa>
			<title>Mortality of Pulmonary Artery Banding</title>
			<subject_fa></subject_fa>
			<subject></subject>
			<content_type_fa></content_type_fa>
			<content_type>Original Article</content_type>
			<abstract_fa></abstract_fa>
			<abstract>&lt;p&gt;Although pulmonary artery banding (PAB) seems to be a technically&lt;br /&gt;simple procedure it presents several peculiarities and is related to a significant morbidity&lt;br /&gt;and mortality. We lack information on this procedure in our center.&lt;/p&gt;</abstract>
			<keyword_fa></keyword_fa>
			<keyword>-</keyword>
			<start_page>30</start_page>
			<end_page>33</end_page>
			<web_url>http://www.iscs.org.ir/journals/vol.3/no.2/309/</web_url>
			<author_list>
				
			</author_list>
		</article>
		
		<article>
			<language></language>
			<article_id_issn></article_id_issn>
			<article_id_issn_online></article_id_issn_online>
			<article_id_pubmed></article_id_pubmed>
			<article_id_pii></article_id_pii>
			<article_id_doi></article_id_doi>
			<article_id_iranmedex></article_id_iranmedex>
			<article_id_magiran></article_id_magiran>
			<article_id_sid></article_id_sid>
			<title_fa></title_fa>
			<title>Pulmonary Valve Replacement in Patients With Congenital Heart Disease: Is There Any Place for Mechanical Valves?</title>
			<subject_fa></subject_fa>
			<subject></subject>
			<content_type_fa></content_type_fa>
			<content_type>Original Article</content_type>
			<abstract_fa></abstract_fa>
			<abstract>&lt;p&gt;We would report the results of 112 mechanical valve replacements in the&lt;br /&gt;position of pulmonary valve during 6 years in the Rajaie Heart Center.&lt;/p&gt;</abstract>
			<keyword_fa></keyword_fa>
			<keyword>TOF: Tetralogy of Fallout, PVR: pulmonary valve replacement, SK: Streptokinase</keyword>
			<start_page>18</start_page>
			<end_page>24</end_page>
			<web_url>http://www.iscs.org.ir/journals/vol.3/no.2/307/</web_url>
			<author_list>
				
			</author_list>
		</article>
		
		<article>
			<language></language>
			<article_id_issn></article_id_issn>
			<article_id_issn_online></article_id_issn_online>
			<article_id_pubmed></article_id_pubmed>
			<article_id_pii></article_id_pii>
			<article_id_doi></article_id_doi>
			<article_id_iranmedex></article_id_iranmedex>
			<article_id_magiran></article_id_magiran>
			<article_id_sid></article_id_sid>
			<title_fa></title_fa>
			<title>Does Retrograde Administration of Cardioplegic Solution Improve the Clinical  Outcomes in Primary Coronary Artery Bypass Grafting?</title>
			<subject_fa></subject_fa>
			<subject></subject>
			<content_type_fa></content_type_fa>
			<content_type>Original Article</content_type>
			<abstract_fa></abstract_fa>
			<abstract>&lt;p&gt;The quality of myocardial protection during Coronary Artery Bypass&lt;br /&gt;Grafting (CABG) has a direct effect on post-operative cardiac function, recovery and&lt;br /&gt;complications. The optimal route for delivery of cardioplegia is still in debate in patients&lt;br /&gt;with ischemic heart disease. This prospective randomized clinical study was&lt;br /&gt;designed to assess and compare the use of combined antegrade-retrograde cardioplegia&lt;br /&gt;versus antegrade cardioplegia in providing adequate myocardial preservation during&lt;br /&gt;coronary artery bypass graft surgery.&lt;/p&gt;</abstract>
			<keyword_fa></keyword_fa>
			<keyword>Antegrade Cardioplegia, Myocardial Protection, Retrograde Cardiople-gia.CABG</keyword>
			<start_page>12</start_page>
			<end_page>17</end_page>
			<web_url>http://www.iscs.org.ir/journals/vol.3/no.2/306/</web_url>
			<author_list>
				
			</author_list>
		</article>
		
		<article>
			<language></language>
			<article_id_issn></article_id_issn>
			<article_id_issn_online></article_id_issn_online>
			<article_id_pubmed></article_id_pubmed>
			<article_id_pii></article_id_pii>
			<article_id_doi></article_id_doi>
			<article_id_iranmedex></article_id_iranmedex>
			<article_id_magiran></article_id_magiran>
			<article_id_sid></article_id_sid>
			<title_fa></title_fa>
			<title>Complete Atrioventricular Septal Defect:Comparison of One-Stage Primary Repair With Two-Stage Surgical Strategy</title>
			<subject_fa></subject_fa>
			<subject></subject>
			<content_type_fa></content_type_fa>
			<content_type>Original Article</content_type>
			<abstract_fa></abstract_fa>
			<abstract>&lt;p&gt;Complete Atrioventricular Septal Defect (CAVSD) is a congenital heart&lt;br /&gt;disease treated by surgical repair. There are two strategies for surgery: 1) Primary repair&lt;br /&gt;at lower ages (one-stage repair). 2) PA banding in lower age and then complete&lt;br /&gt;repair after normalization of PAP (Two-stage repair).The purpose of this study was&lt;br /&gt;comparison of mortality rate and short term complications of these two strategies.&lt;/p&gt;</abstract>
			<keyword_fa></keyword_fa>
			<keyword>Complete Atrioventricular Septal Defect; Primary Repair; Two StageRepair; Pulmonary Artery Banding.</keyword>
			<start_page>7</start_page>
			<end_page>11</end_page>
			<web_url>http://www.iscs.org.ir/journals/vol.3/no.2/305/</web_url>
			<author_list>
				
			</author_list>
		</article>
		
		<article>
			<language></language>
			<article_id_issn></article_id_issn>
			<article_id_issn_online></article_id_issn_online>
			<article_id_pubmed></article_id_pubmed>
			<article_id_pii></article_id_pii>
			<article_id_doi></article_id_doi>
			<article_id_iranmedex></article_id_iranmedex>
			<article_id_magiran></article_id_magiran>
			<article_id_sid></article_id_sid>
			<title_fa></title_fa>
			<title>Early Diagnosis of Cardiac Involvement in β-Thalassemia Major</title>
			<subject_fa></subject_fa>
			<subject></subject>
			<content_type_fa></content_type_fa>
			<content_type>Original Article</content_type>
			<abstract_fa></abstract_fa>
			<abstract>&lt;p&gt;Cardiac involvement is the major cause of morbidity and death in (&amp;beta;)-&lt;br /&gt;thalassemia Major. We aimed to compare echocardiography findings in early diagnosis&lt;br /&gt;of cardiac involvement.&lt;/p&gt;</abstract>
			<keyword_fa></keyword_fa>
			<keyword>Beta (β)-thalassemia Major; Systolic and diastolic dysfunction; Echocar-diography</keyword>
			<start_page>3</start_page>
			<end_page>6</end_page>
			<web_url>http://www.iscs.org.ir/journals/vol.3/no.2/304/</web_url>
			<author_list>
				
			</author_list>
		</article>
		
	</articleset>
</journal>

